Preview

User

Not a user? Register with this site Forgot your password?

Problems of Endocrinology

Advanced search

Galectin-3 expression in preoperative diagnosis of highly differentiated thyroid cancer

https://doi.org/10.14341/probl20105649-15

Abstract

Galectin-3 expression in fine-needle aspiration biopsies from 66 patients with thyroid Nodes (TN) was studied by flow fluorocytometry (FFC). Cytological study revealed 29 patients with papillary thyroid cancer, 31 with follicular tumour, and 6 with colloid nodular goiter. Galectin-3 expression was documented in 27 of the 29 patients with preoperative diagnosis of papillary cancer; in 25 (92.6%) of these cases diagnosis of highly differentiated cancer was confirmed histologically, the remaining 2 (7.4%) cases presented with benign thyroid disease. Two (6.9%) patients without galectin-3 expression had papillary cancer. In the group of patients with cytologically verified diagnosis of follicular tumour, galectin-3 expresion occurred in 2 with highly differentiated (papillary and follicular) thyroid cancer and in 2 with follicular and oncocytic thyroid adenoma. The remaining 27 patients with benign neoplasms did not show expression of galectin-3. Nor was it detected in 6 (100%) patients with colloid nodular goiter. Sensitivity of flow fluorocytometry for detection of galectin-3 expression in thyroid node aspirates was estimated at 93.1%, specificity 89.2%, diagnostic precision 90.9%. It is concluded that this method may be used as an additional tool for preoperative diagnosis of high-differentiated thyroid cancer.

References

1. Хмельницкий О.К. Цитологическая и гистологическая диагностика заболеваний щитовидной железы. Ст-Петербург: Сотис 2002; 288.

2. Cibas E.S., Ducatmann B.S. Cytology. Diagnos principles and clinical correlates. WB Sunders company. Philadelphia, London, Toronto, Montreal, Sydney, Tokyo: A division of Harcourt Brace Company. 1996; 217-242.

3. Gharib H. Fine-needle aspiration biopsy of thyroid nodules: advantages, limitation, and effect. Mayo Clin Proc 1994; 69: 44-49.

4. Saggiorato E., Cappia S., De Giuli P., Mussa A. Galectin-3 as a presurgical immunocytodiagnostic marker of minimally invasive follicular thyroid carcinoma. J Clin Endocrinol Metab 2001; 86: 11: 5152-5158.

5. Yu L.G., Andrews N., Zhao Q. Galectin-3 interaction with Thomsen-Friedenreich disaccharide on cancer-associated MUC1 causes increased cancer cell endothelial adhesion. J Biol Chem 2007; 282: 1: 773-781.

6. Bernet V.J., Anderson J., Vaishnav Y., Solomon B. Determination of galectin-3 messenger ribonucleic Acid overexpression in papillary thyroid cancer by quantitative reverse transcription-polymerase chain reaction. J Clin Endocrinol Metab 2002; 87: 10: 4792-4796.

7. Bartolazzi A., Gasbarri A., Papotti M. et al. The Thyroid Cancer Study Group Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet 2001; 357: 9272: 1982.

8. Matos P.S., Ferreira A.P., de Oliveira Facuri F. et al. Usefulness of HBME-1, cytokeratin 19 and galectin-3 immunostaining in the diagnosis of thyroid malignancy. Histopathology 2005; 47: 4: 391-401.

9. Saggiorato E., De Pompa R., Volante M. Characterization of thyroid "follicular neoplasms" in fine-needle aspiration cytological specimens using a panel of immunohistochemical markers: a proposal for clinical application. Endocr Relat Cancer 2005; 12: 2: 305-331.

10. Bartolazzi A., Orlandi F., Saggiorato E., Volante M. Galectin-3-expression analysis in the surgical selection of follicular thyroid nodules with indeterminate fine-needle aspiration cytology: a prospective multicentre study. Lancet Oncol 2008; 9: 6: 508-510.

11. Rossi E.D., Raffaelli M., Mule A. Simultaneous immunohistochemical expression of HBME-1 and galectin-3 differentiates papillary carcinomas from hyperfunctioning lesions of the thyroid. Histopathology 2006; 48: 7: 795-800.

12. Linn S. A new conceptual approach to teaching the interpretation of clinical tests. J Statistics Education 2004; 12: 3.


Review

For citations:

Semenov D.I., Koloskova L.E., Boriskova M.E., Pankova P.A., Feshchenko N.S., Filippova O.I.,  Farafonova U.V. Galectin-3 expression in preoperative diagnosis of highly differentiated thyroid cancer. Problems of Endocrinology. 2010;56(4):9-15. https://doi.org/10.14341/probl20105649-15

Views: 377


ISSN 0375-9660 (Print)
ISSN 2308-1430 (Online)

11, Dm. Ul’yanova str., Moscow, Russian Federation, 117292

Processing of personal data
supported by NEICON (Elpub lab)